Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
NCT02061813
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Head Lice
Interventions
DRUG:
Abametapir Lotion 0.74% w/w
DRUG:
Sodium Lauryl Sulfate
DRUG:
Saline 0.9%
DRUG:
Placebo
Sponsor
Dr. Reddy's Laboratories Limited